TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
Go back to TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial| (NASDAQ: TMDX) | Delayed: 83.89 +3.68 (4.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.21 | 52 Week High | $ | |||
| Open | $81.00 | 52 Week Low | $ | |||
| Day High | $83.98 | P/E | N/A | |||
| Day Low | $79.51 | EPS | $ | |||
| Volume | 772,188 | |||||
